Citations

Clear

1053 citation(s) found for "Andre, F".

Regeneration for All: An Odyssey in Biotherapy
Behfar, Atta , Behfar, Atta , Terzic, André

Mayo Clinic

European Heart Journal | April 1, 2019 | Volume: 40 | Issue: 13 | Pages: 1033-1035

10.1093/eurheartj/ehz095 | PMID 30933287 Get It

A Versatile Protocol for Studying Anterior Cruciate Ligament Reconstruction in a Rabbit Model
Crispim, João F. , Paggi, Carlo Alberto , Dudakovic, Amel , Genechten, Wouter Van , Hewett, Timothy E. , Krych, Aaron J. , Wijnen, André J. van , Saris, Daniël B.F. , Paggi, Carlo A, van Genechten, Wouter, Hewett, Timothy, van Wijnen, Andre J , Krych, Aaron J , Hevesi, Mario , Kakar, Sanjeev

Mayo Clinic

Tissue Engineering Part C: Methods | March 19, 2019 | Volume: 25 | Issue: 4 | Pages: 191-196

10.1089/ten.tec.2018.0357 | PMID 30887885 Get It

Higher order genomic organization and epigenetic control maintain cellular identity and prevent breast cancer
Fritz, Andrew J. , Gerrard, Diana L., Hong, David I. , Rose, Joshua T., Ghule, Prachi N. , Bolf, Eric L. , Gordon, Jonathan , Tracy, Kirsten M. , Nickerson, Jeffrey A. , Wijnen, André J. van , Imbalzano, Anthony N. , Heath, Jessica L. , Frietze, Seth , Zaidi, Sayyed K. , Carr, Frances E. , Lian, Jane B. , Stein, Janet L. , Fritz, A J , Stein, Gary S , van Wijnen, Andre J , Tracy, Kirsten M , Gillis, Noelle E. , Rodriguez, Princess D. , Hong, D., Gordon, J.A., Tye, Coralee E. , Boyd, Joseph R. , Stein, Gary S.

Mayo Clinic

Genes, Chromosomes and Cancer | March 15, 2019 | Volume: 58 | Issue: 7 | Pages: 484-499

10.1002/gcc.22731 | PMID 30873710 Get It

Cells establish and sustain structural and functional integrity of the genome to support cellular identity and prevent malignant transformation. In this review, we present a strategic overview of epigenetic regulatory mechanisms including histone modifications and higher order chromatin organization (HCO) that are perturbed in breast cancer onset and progression. Implications for dysfunctions that occur in hormone regulation, cell cycle control, and mitotic bookmarking in breast cancer are considered, with an emphasis on epithelial‐to‐mesenchymal transition and cancer stem cell activities. The architectural organization of regulatory machinery is addressed within the contexts of translating cancer‐compromised genomic organization to advances in breast cancer risk assessment, diagnosis, prognosis, and identification of novel therapeutic targets with high specificity and minimal off target effects.
Determinants of early mortality in 37,568 colon cancer patients participating in 25 clinical trials of the ACCENT database.
Renfro, Lindsay A. , Haller, Daniel G. , Twelves, Chris , Guthrie, Katherine A. , Gramont, Aimery de , Allegra, Carmen J. , Group, ACCENT Collaborative, Cheung, Winson Y. , Yothers, Greg , Gray, Richard , André, Thierry , Cutsem, Eric Van , Saltz, Leonard B. , Grothey, Axel , Labianca, Roberto , Alberts, Steven R. , Schmoll, Hans‐Joachim , Sargent, Daniel J. , Group, ACCENT Collaborative

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 6580-6580

10.1200/jco.2015.33.15_suppl.6580 Get It

Activating genomic mutations in the mTOR pathway to predict responses to everolimus and temsirolimus in patients with metastatic renal cell carcinoma (mRCC): Results from a large multi-institutional cohort.
Fay, André P. , Gray, Kathryn P. , Song, Jiaxi , Barrios, Pablo M. , Albigès, Laurence , Krajewski, Katherine M. , Pal, Sumanta K. , Heng, Daniel Yick Chin, Kwiatkowski, David J. , Thorner, Aaron R. , Rini, Brian I. , Agarwal, Neeraj , Ho, Thai H. , Van Allen, Eliezer M , Porta, Camillo , Bellmunt, Joaquim , McDermott, David F. , Signoretti, Sabina , Choueiri, Toni K.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 4519-4519

10.1200/jco.2015.33.15_suppl.4519 Get It

Time-dependent patterns of recurrence and death in resected colon cancer (CC): Pooled analysis of 12,223 patients from modern trials in the ACCENT database containing oxaliplatin.
Renfro, Lindsay A. , Allegra, Carmen J. , Gramont, Aimery de , Haller, Daniel G. , Shah, Manish A , André, Thierry , Sinicrope, Frank A. , Schmoll, Hans‐Joachim , Alberts, Steven R. , Yothers, Greg , Sargent, Daniel J.

Mayo Clinic

Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 3593-3593

10.1200/jco.2015.33.15_suppl.3593 Get It

AIDS-Related Kaposi Sarcoma, Version 2.2019
Suneja, Gita , Ambinder, Richard F. , Ard, Kevin L. , Baiocchi, Robert A. , Cohen, Adam K. , Crysler, Oxana , Gupta, Neel K. , Gustafson, Chelsea, Hall, Andre, Johung, Kimberly L. , LaCasce, Ann S. , Lin, Chi , Menon, Manoj , Morgan, David , Nathwani, Nitya , Ratner, Lee , Rizza, Stacey A. , Sanchez, Julian , Taylor, Jeff , Tomlinson, Benjamin , Wang, Chia-Ching J., Dwyer, Mary A., CGC, Freedman-Cass, Deborah A., Rizza, Stacey , Ratner, Lee , Reid, Erin G , Barta, Stefan K , Carchman, Evie H. , Klopp, Ann H. , Mehta, Amitkumar , Noy, Ariela , Rudek, Michelle A. , Yendamuri, Sai S , CGC, Freedman-Cass, Deborah A., Ambinder, Richard F

Mayo Clinic

Journal of the National Comprehensive Cancer Network | February 20, 2019 | Volume: 17 | Issue: 2 | Pages: 171-189

10.6004/jnccn.2019.0008 | PMID 30787130 Get It

As treatment of HIV has improved, people living with HIV (PLWH) have experienced a decreased risk of AIDS and AIDS-defining cancers (non-Hodgkin’s lymphoma, Kaposi sarcoma, and cervical cancer), but the risk of Kaposi sarcoma in PLWH is still elevated about 500-fold compared with the general population in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AIDS-Related Kaposi Sarcoma provide diagnosis, treatment, and surveillance recommendations for PLWH who develop limited cutaneous Kaposi sarcoma and for those with advanced cutaneous, oral, visceral, or nodal disease.
Effect of Lidocaine on Viability and Gene Expression of Human Adipose–derived Mesenchymal Stem Cells: An in vitro Study
Nie, Hai , Kubrova, Eva , Denbeigh, Janet M. , Dietz, Allan B. , Smith, Jay , Qu, Wenchun , Wijnen, André J. van , Hunt, Christine , van Wijnen, Andre J , Dietz, Allan B , Wu, Tao , Hunt, Christine

Mayo Clinic

PM&R | February 20, 2019 | Volume: 11 | Issue: 11 | Pages: 1218-1227

10.1002/pmrj.12141 | PMID 30784215 Get It

ObjectiveTo assess the biologic effects of lidocaine on the viability, proliferation, and function of human adipose tissue–derived mesenchymal stromal/stem cells (MSCs) in vitro.MethodsAdipose‐derived MSCs from three donors were exposed to lidocaine at various dilutions (2 mg/mL to 8 mg/mL) and exposure times (0.5 to 4 hours). Cell number and viability, mitochondrial activity, and real‐time reverse‐transcriptase quantitative polymerase chain reaction (RT‐qPCR) were analyzed at 0 (immediate effects) or 24 and 48 hours (recovery effects) after treatment with lidocaine.ResultsTrypan blue staining showed that increasing concentrations of lidocaine decreased the number of observable viable cells. 3‐[4,5,dimethylthiazol‐2‐yl]‐5‐[3‐carboxymethoxy‐phenyl]‐2‐[4‐sulfophenyl]‐2H‐tetrazolium (MTS) assays revealed a concentration‐ and time‐ dependent decline of mitochondrial activity and proliferative ability. Gene expression analysis by RT‐qPCR revealed that adipose‐derived MSCs exposed to lidocaine express robust levels of stress response/cytoprotective genes. However, higher concentrations of lidocaine caused a significant downregulation of these genes. No significant differences were observed in expression of extracellular matrix (ECM) markers COL1A1 and DCN except for COL3A1 (P < .05). Levels of messenger RNA (mRNA) for proliferation markers (CCNB2, HIST2H4A, P < .001) and MKI67 (P < .001) increased at 24 and 48 hours. Expression levels of several transcription factors— including SP1, PRRX1, and ATF1—were modulated in the same manner. MSC surface markers CD44 and CD105 demonstrated decreased expression immediately after treatment, but at 24 and 48 hours postexposure, the MSC markers showed no significant difference among groups.ConclusionLidocaine is toxic to MSCs in a dose‐ and time‐ dependent manner. MSC exposure to high (4‐8 mg/mL) concentrations of lidocaine for prolonged periods can affect their biologic functions. Although the exposure time in vivo is short, it is essential to choose safe concentrations when applying lidocaine along with MSCs to avoid compromising the viability and potency of the stem cell therapy.
Occupational medicine clinical practice data reveal increased injury rates among Hispanic workers
Riester, Scott M. , Leniek, Karyn , Niece, Ashley D., Montoya‐Barthelemy, Andre , Wilson, W. David, Sellman, Jonathan, Anderson, Paul J., Bannister, Emily L., Bovard, Ralph , Kilbride, Karis A., Koos, Kirsten M., McKinney, Zeke J. , Abrar, Fozia A., Kim, Hyun , McKinney, Zeke J , Wilson, William

Mayo Clinic

American Journal of Industrial Medicine | January 30, 2019 | Volume: 62 | Issue: 4 | Pages: 309-316

10.1002/ajim.22949 | PMID 30697792 Get It

Background Minnesota has an ethnically diverse labor force, with the largest number of refugees per capita in the United States. In recent years, Minnesota has been and continues to be a major site for immigrant and refugee resettlement in the United States, with a large population of both immigrant and native born Hmong, Hispanic, and East Africans. This study seeks to evaluate the injury risk among the evolving minority workforce in the Minnesota Twin Cities region. Methods A retrospective cohort study identifying work‐related injuries following pre‐employment examinations was performed using electronic health records from a large multi‐clinic occupational medicine practice. Preplacement examinations and subsequent work‐related injuries were pulled from the electronic health record using representative ICD‐10 codes for surveillance examinations and injuries. This study included patient records collected over a 2‐year period from January 1, 2015, through December, 2016. The patients in this cohort worked in a wide‐array of occupations including production, assembly, construction, law enforcement, among others. Results Hispanic minority workers were twice as likely to be injured at work compared with White workers. Hispanics were 2.89 times more likely to develop back injuries compared with non‐Hispanic workers, and 1.86 times more likely to develop upper extremity injuries involving the hand, wrist, or elbow. Conclusion Clinical practice data shows that Hispanic workers are at increased risk for work‐related injuries in Minnesota. They were especially susceptible to back and upper extremity injuries. Lower injury rates in non‐Hispanic minority workers, may be the result of injury underreporting and require further investigation.
The cancer‐related transcription factor RUNX2 modulates expression and secretion of the matricellular protein osteopontin in osteosarcoma cells to promote adhesion to endothelial pulmonary cells and lung metastasis
Villanueva, Francisco , Briceño, Pedro, Varela, Nelson , Stevenson, A.E., Jerez, Sofía , Tempio, Fabián , Chnaiderman, Jonás , Perez, Carola, Villarroel, Milena , Concha, Emma , Khani, Farzaneh , Thaler, Roman , Salazar‐Onfray, Flavio , Wijnen, André J. van , Galindo, Mario , van Wijnen, Andre J , Galindo, Mario A , Araya, Hector, Stein, Gary S.

Mayo Clinic

Journal of Cellular Physiology | January 14, 2019 | Volume: 234 | Issue: 8 | Pages: 13659-13679

10.1002/jcp.28046 | PMID 30637720 Get It

Abstract Osteosarcomas are bone tumors that frequently metastasize to the lung. Aberrant expression of the transcription factor, runt‐related transcription factor 2 (RUNX2), is a key pathological feature in osteosarcoma and associated with loss of p53 and miR‐34 expression. Elevated RUNX2 may transcriptionally activate genes mediating tumor progression and metastasis, including the RUNX2 target gene osteopontin ( OPN/SPP1 ). This gene encodes a secreted matricellular protein produced by osteoblasts to regulate bone matrix remodeling and tissue calcification. Here we investigated whether and how the RUNX2/OPN axis regulates lung metastasis of osteosarcoma. Importantly, RUNX2 depletion attenuates lung metastasis of osteosarcoma cells in vivo. Using next‐generation RNA‐sequencing, protein‐based assays, as well as the loss‐ and gain‐of‐function approaches in selected osteosarcoma cell lines, we show that osteopontin messenger RNA levels closely correlate with RUNX2 expression and that RUNX2 controls the levels of secreted osteopontin. Elevated osteopontin levels promote heterotypic cell–cell adhesion of osteosarcoma cells to human pulmonary microvascular endothelial cells, but not in the presence of neutralizing antibodies. Collectively, these findings indicate that the RUNX2/OPN axis regulates the ability of osteosarcoma cells to attach to pulmonary endothelial cells as a key step in metastasis of osteosarcoma cells to the lung.